GlaxoSmithKline (GSK) has told us it is having problems with the supply of Lamictal. This is due to manufacturing problems.
50 mg tablets: low in stock. The current stock is due to last until the end of January. GSK don’t know when they will be back in stock.
100 mg tablets: low in stock. GSK expects stock to be back to normal on 6 February.
200 mg tablets: stock levels are normal.
When we get an update on this situation we will update this page.
If you have any concerns about this please speak to your doctor or epilepsy nurse.
Epilepsy Action Helpline Team